Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5318)
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
23,865
Price
$26.05
Total Value
$621.67K
Shares Held After
319,079
% of Holdings
7.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,227
Price
$546.00
Total Value
$669.94K
Shares Held After
40,513
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,407
Price
$545.19
Total Value
$1.86M
Shares Held After
41,740
% of Holdings
7.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,329
Price
$544.29
Total Value
$723.36K
Shares Held After
45,147
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
900
Price
$543.10
Total Value
$488.79K
Shares Held After
46,476
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,444
Price
$542.13
Total Value
$782.83K
Shares Held After
47,376
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
894
Price
$540.99
Total Value
$483.64K
Shares Held After
48,820
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
299
Price
$540.24
Total Value
$161.53K
Shares Held After
49,714
% of Holdings
0.6%
Aquestive Therapeutics, Inc. (AQST)
Krop Julie — Director
Shares
25,000
Price
$5.02
Total Value
$125.39K
Shares Held After
0
% of Holdings
100.0%
Spyre Therapeutics, Inc. (SYRE)
Fairmount Funds Management LLC — Director
Shares
4,684,781
Price
$85.31
Total Value
$399.66M
Shares Held After
0
% of Holdings
100.0%
NEXGEL, INC. (NXGL)
Levy Adam R. — Director
Shares
5,000
Price
$0.59
Total Value
$2.97K
Shares Held After
322,692
% of Holdings
1.5%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
3,500
Price
$79.51
Total Value
$278.29K
Shares Held After
153,902
% of Holdings
2.2%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
8,118
Price
$71.20
Total Value
$578.00K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
41,964
Price
$71.20
Total Value
$2.99M
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
1,217
Price
$71.20
Total Value
$86.65K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
51,176
Price
$71.20
Total Value
$3.64M
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
9,658
Price
$70.75
Total Value
$683.28K
Shares Held After
8,118
% of Holdings
54.3%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
49,929
Price
$70.75
Total Value
$3.53M
Shares Held After
41,964
% of Holdings
54.3%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
1,449
Price
$70.75
Total Value
$102.51K
Shares Held After
1,217
% of Holdings
54.4%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
60,888
Price
$70.75
Total Value
$4.31M
Shares Held After
51,176
% of Holdings
54.3%
Quantum-Si Inc (QSI)
Keyes Jeffry R. — Chief Financial Officer
Shares
4,116
Price
$0.96
Total Value
$3.94K
Shares Held After
1,728,466
% of Holdings
0.2%
Quantum-Si Inc (QSI)
Vieceli John S. — Chief Product Officer
Shares
15,111
Price
$0.96
Total Value
$14.47K
Shares Held After
1,155,546
% of Holdings
1.3%
Disc Medicine, Inc. (IRON)
Yu Jonathan Yen-Wen — Chief Operating Officer
Shares
9,700
Price
$72.66
Total Value
$704.80K
Shares Held After
54,324
% of Holdings
15.2%
Quantum-Si Inc (QSI)
Hawkins Jeffrey Alan — Director
Shares
11,310
Price
$0.96
Total Value
$10.83K
Shares Held After
3,681,113
% of Holdings
0.3%
Quantum-Si Inc (QSI)
LaPointe Christian — GC & Corp. Secretary
Shares
7,794
Price
$0.96
Total Value
$7.46K
Shares Held After
1,190,223
% of Holdings
0.7%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
65,000
Price
$0.04
Total Value
$2.92K
Shares Held After
93,694,319
% of Holdings
0.1%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Bergmann Anthony — CHIEF FINANCIAL OFFICER
Shares
500
Price
$30.00
Total Value
$15.00K
Shares Held After
11,223
% of Holdings
4.3%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Krasney Karen — EVP, GENERAL COUNSEL
Shares
500
Price
$30.00
Total Value
$15.00K
Shares Held After
30,547
% of Holdings
1.6%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
80,000
Price
$132.54
Total Value
$10.60M
Shares Held After
1,015,987
% of Holdings
7.3%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
26,400
Price
$132.60
Total Value
$3.50M
Shares Held After
179,248
% of Holdings
12.8%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
580
Price
$13.95
Total Value
$8.09K
Shares Held After
194,075
% of Holdings
0.3%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
3,382
Price
$13.95
Total Value
$47.18K
Shares Held After
936,252
% of Holdings
0.4%
OnKure Therapeutics, Inc. (OKUR)
Leverone Jason A. — Chief Financial Officer
Shares
303
Price
$4.40
Total Value
$1.33K
Shares Held After
18,802
% of Holdings
1.6%
OnKure Therapeutics, Inc. (OKUR)
Saccomano Nicholas A — Director
Shares
86
Price
$4.40
Total Value
$378.08
Shares Held After
11,247
% of Holdings
0.8%
Septerna, Inc. (SEPN)
Long Daniel D. — SVP, Drug Discovery
Shares
7,000
Price
$35.97
Total Value
$251.78K
Shares Held After
96,412
% of Holdings
6.8%
Septerna, Inc. (SEPN)
Long Daniel D. — SVP, Drug Discovery
Shares
8,000
Price
$35.10
Total Value
$280.80K
Shares Held After
103,412
% of Holdings
7.2%
Enliven Therapeutics, Inc. (ELVN)
ORBIMED ADVISORS LLC — 10% Owner
Shares
46,776
Price
$45.00
Total Value
$2.10M
Shares Held After
6,555,102
% of Holdings
0.7%
Enliven Therapeutics, Inc. (ELVN)
ORBIMED ADVISORS LLC — 10% Owner
Shares
787,024
Price
$45.38
Total Value
$35.72M
Shares Held After
6,601,878
% of Holdings
10.7%
Enliven Therapeutics, Inc. (ELVN)
ORBIMED ADVISORS LLC — 10% Owner
Shares
1,477
Price
$45.00
Total Value
$66.47K
Shares Held After
219,405
% of Holdings
0.7%
Enliven Therapeutics, Inc. (ELVN)
ORBIMED ADVISORS LLC — 10% Owner
Shares
24,846
Price
$45.38
Total Value
$1.13M
Shares Held After
220,882
% of Holdings
10.1%
Faeth Therapeutics, Inc. (FTH)
Parikh Anand Kiran — Director
Shares
2,806
Price
$19.76
Total Value
$55.45K
Shares Held After
764,234
% of Holdings
0.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
356
Price
$23.95
Total Value
$8.53K
Shares Held After
8,183
% of Holdings
4.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
3,329
Price
$23.28
Total Value
$77.50K
Shares Held After
7,827
% of Holdings
42.5%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,583
Price
$22.40
Total Value
$35.46K
Shares Held After
4,498
% of Holdings
35.2%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,118
Price
$20.82
Total Value
$23.28K
Shares Held After
2,915
% of Holdings
38.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,797
Price
$20.23
Total Value
$36.35K
Shares Held After
1,797
% of Holdings
100.0%
BioCardia, Inc. (BCDA)
STERTZER SIMON H — Director
Shares
70,200
Price
$0.92
Total Value
$64.58K
Shares Held After
127,338
% of Holdings
55.1%
Arcus Biosciences, Inc. (RCUS)
Jaen Juan C. — President
Shares
9,236
Price
$27.03
Total Value
$249.66K
Shares Held After
913,004
% of Holdings
1.0%
BridgeBio Pharma, Inc. (BBIO)
Valantine Hannah — Director
Shares
2,808
Price
$68.00
Total Value
$190.94K
Shares Held After
11,455
% of Holdings
19.7%
Aditxt, Inc. (ADTX)
HRT FINANCIAL LP — 10% Owner
Shares
5,120,480
Price
$0.02
Total Value
$92.17K
Shares Held After
0
% of Holdings
100.0%
Showing 51–100 of 5318 transactions (page 2 of 107)